Back to Search
Start Over
The structural role of receptor tyrosine sulfation in chemokine recognition
- Source :
- British Journal of Pharmacology. 171:1167-1179
- Publication Year :
- 2014
- Publisher :
- Wiley, 2014.
-
Abstract
- Tyrosine sulfation is a post-translational modification of secreted and transmembrane proteins, including many GPCRs such as chemokine receptors. Most chemokine receptors contain several potentially sulfated tyrosine residues in their extracellular N-terminal regions, the initial binding site for chemokine ligands. Sulfation of these receptors increases chemokine binding affinity and potency. Although receptor sulfation is heterogeneous, insights into the molecular basis of sulfotyrosine (sTyr) recognition have been obtained using purified, homogeneous sulfopeptides corresponding to the N-termini of chemokine receptors. Receptor sTyr residues bind to a shallow cleft defined by the N-loop and β3-strand elements of cognate chemokines. Tyrosine sulfation enhances the affinity of receptor peptides for cognate chemokines in a manner dependent on the position of sulfation. Moreover, tyrosine sulfation can alter the selectivity of receptor peptides among several cognate chemokines for the same receptor. Finally, binding to receptor sulfopeptides can modulate the oligomerization state of chemokines, thereby influencing the ability of a chemokine to activate its receptor. These results increase the motivation to investigate the structural basis by which tyrosine sulfation modulates chemokine receptor activity and the biological consequences of this functional modulation. Linked ArticlesThis article is part of a themed section on Molecular Pharmacology of GPCRs. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue-5
- Subjects :
- Pharmacology
CCR1
Tyrosine sulfation
0303 health sciences
C-C chemokine receptor type 7
C-C chemokine receptor type 6
Biology
03 medical and health sciences
Chemokine receptor
0302 clinical medicine
Biochemistry
Chemokine binding
030220 oncology & carcinogenesis
XCL2
030304 developmental biology
CCL21
Subjects
Details
- ISSN :
- 00071188
- Volume :
- 171
- Database :
- OpenAIRE
- Journal :
- British Journal of Pharmacology
- Accession number :
- edsair.doi...........d50c526a0cfe92c542f5bf6edecf4d16
- Full Text :
- https://doi.org/10.1111/bph.12455